{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:15:41Z","timestamp":1777392941821,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:p>Background: Association between visual field test indices and The Consortium to Establish a Registry for Alzheimer\u2019s Disease Neuropsychological Battery (CERAD-NB) is unknown. Idiopathic normal pressure hydrocephalus (iNPH) patients provide a unique set of patient data for analysis. Objective: To assess the reliability of visual field testing using the CERAD-NB in patients with iNPH and to investigate the association between visual field test results and cognitive function. Methods: 62 probable iNPH patients were subjected to comprehensive ophthalmological examination, ophthalmological optical coherence tomography imaging studies, visual field testing, and CERAD-NB. Based on visual field indices, the patients were divided into two groups: unreliable (n\u200a=\u200a19) and reliable (n\u200a=\u200a43). Independent T-test analysis was performed to examine the relationship between visual field test results and cognitive function. Pearson Chi-square test was used for non-continuous variables. Results: The unreliable group performed worse in CERAD-NB subtests compared to the reliable group. Statistically significant differences were observed in nine out of ten subtests, with only Clock Drawing showing no statistical significance. Pairwise comparison of the groups showed no statistical significance between amyloid-\u03b2 (A\u03b2) biopsy, hyperphosphorylated tau biopsy, apolipoprotein E allele or the ophthalmological status of the patient. But there was a statistically significant difference in cerebrospinal fluid A\u03b242 and age between the groups. Conclusions: Patients with unreliable visual field tests performed worse on CERAD-NB subtests. CERAD-NB subtests do not provide a specific cut-off value to refrain patients from visual field testing. Should patients with unreliable visual field tests be screened for cognitive impairment?<\/jats:p>","DOI":"10.3233\/jad-231414","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:59:49Z","timestamp":1717509589000},"page":"247-260","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients"],"prefix":"10.1177","volume":"100","author":[{"given":"Benjam","family":"Kemil\u00e4inen","sequence":"first","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and Unit of Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"},{"name":"Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Tiainen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and Unit of Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas","family":"Rauramaa","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"},{"name":"Department of Pathology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti J.","family":"Luikku","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and Unit of Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[{"name":"Neurology of NeuroCenter, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Koivisto","sequence":"additional","affiliation":[{"name":"Unit of Neurosciences, Faculty of Medicine, University of Helsinki, Helsinki, Finland"},{"name":"Geriatrics\/Internal Medicine and Rehabilitation, Helsinki University Hospital, Helsinki, Finland"},{"name":"Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Verdooner","sequence":"additional","affiliation":[{"name":"NeuroVision Imaging Inc., Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Johnson","sequence":"additional","affiliation":[{"name":"NeuroVision Imaging Inc., Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieko","family":"Chambers","sequence":"additional","affiliation":[{"name":"NeuroVision Imaging Inc., Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland"},{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Neurosurgery of NeuroCenter, Kuopio University Hospital and Unit of Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-231414_ref1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2176\/nmc.st.2020-0292","article-title":"Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus","volume":"61","author":"Nakajima","year":"2021","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.3233\/JAD-231414_ref2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3171\/2018.5.JNS1875","article-title":"Outcomes and complications of different surgical treatments for idiopathic normal pressure hydrocephalus: A systematic review and meta-analysis","volume":"131","author":"Giordan","year":"2018","journal-title":"J Neurosurg"},{"key":"10.3233\/JAD-231414_ref3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/mds.28251","article-title":"Gaps, controversies, and proposed roadmap for research in normal pressure hydrocephalus","volume":"35","author":"Fasano","year":"2020","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-231414_ref4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","article-title":"Prevalence of idiopathic normal-pressure hydrocephalus","volume":"82","author":"Jaraj","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-231414_ref5","first-page":"217","article-title":"A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus","volume":"30","author":"Picascia","year":"2015","journal-title":"Funct Neurol"},{"key":"10.3233\/JAD-231414_ref6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ane.13052","article-title":"Structural correlates of cognitive impairment in normal pressure hydrocephalus","volume":"139","author":"Peterson","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-231414_ref7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JAD-201363","article-title":"The CERAD Neuropsychological Battery in patients with idiopathic normal pressure hydrocephalus compared with normal population and patients with mild Alzheimer\u2019s disease","volume":"81","author":"Nerg","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-231414_ref8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-190334","article-title":"Predicting development of Alzheimer\u2019s disease in patients with shunted idiopathic normal pressure hydrocephalus","volume":"71","author":"Luikku","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-231414_ref9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jalz.2007.08.005","article-title":"Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD): The first twenty years","volume":"4","author":"Fillenbaum","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-231414_ref10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-0404.2010.01459.x","article-title":"CERAD-neuropsychological battery in screening mild Alzheimer\u2019s disease","volume":"125","author":"Sotaniemi","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-231414_ref11","doi-asserted-by":"crossref","first-page":"e1061","DOI":"10.1016\/j.wneu.2021.01.003","article-title":"Optical coherence tomography revealing ganglion cell loss in idiopathic normal pressure hydrocephalus","volume":"149","author":"Eleftheriou","year":"2021","journal-title":"World Neurosurg"},{"key":"10.3233\/JAD-231414_ref12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41433-018-0042-2","article-title":"Normal tension glaucoma: Review of current understanding and mechanisms of the pathogenesis","volume":"32","author":"Killer","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.3233\/JAD-231414_ref13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41598-019-39526-2","article-title":"Optic disc cupping characteristics of normal pressure hydrocephalus patients with normal-tension glaucoma","volume":"9","author":"Igarashi","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-231414_ref14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/medicina57030234","article-title":"Can the treatment of normal-pressure hydrocephalus induce normal-tension glaucoma? A narrative review of a current knowledge","volume":"57","author":"Hamarat","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.3233\/JAD-231414_ref15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cxo.12551","article-title":"The value of visual field testing in the era of advanced imaging: Clinical and psychophysical perspectives","volume":"100","author":"Phu","year":"2017","journal-title":"Clin Exp Optom"},{"key":"10.3233\/JAD-231414_ref16","volume-title":"Excellent Perimetry; the Field Analyzer Primer","author":"Heijl","year":"2021"},{"key":"10.3233\/JAD-231414_ref17","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2017.04.035","article-title":"Evidence-based criteria for assessment of visual field reliability","volume":"124","author":"Yohannan","year":"2017","journal-title":"Ophthalmology"},{"key":"10.3233\/JAD-231414_ref18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/IJG.0000000000001269","article-title":"The association between visual field reliability indices and cognitive impairment in glaucoma patients","volume":"28","author":"Raman","year":"2019","journal-title":"J Glaucoma"},{"key":"10.3233\/JAD-231414_ref19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/0004-282x-anp-2021-0134","article-title":"Optical coherence tomography in neurodegenerative disorders","volume":"80","author":"Cunha","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"10.3233\/JAD-231414_ref20","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-231414_ref21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-231414_ref22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","article-title":"CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings","volume":"78","author":"Sepp\u00e4l\u00e4","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-231414_ref23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12987-019-0142-9","article-title":"The Kuopio idiopathic normal pressure hydrocephalus protocol: Initial outcome of 175 patients","volume":"16","author":"Junkkari","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-231414_ref24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.31887\/DCNS.2004.6.4\/hhampel","article-title":"CSF tau and \u03b2-amyloid as biomarkers for mild cognitive impairment","volume":"6","author":"Hampel","year":"2004","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-231414_ref25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/jnnp-2019-320826","article-title":"CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics","volume":"90","author":"Jeppsson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-231414_ref26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp-2011-303849","article-title":"APOE4 predicts amyloid-\u03b2 in cortical brain biopsy but not idiopathic normal pressure hydrocephalus","volume":"83","author":"Pyykk\u00f6","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-231414_ref27","first-page":"598","article-title":"Determination by PCR-RFLP of apo E genotype in a Japanese population","volume":"121","author":"Tsukamoto","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.3233\/JAD-231414_ref28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-981-13-1117-8_5","volume-title":"Aging and Aging-Related Diseases: Mechanisms and Interventions","author":"Yin","year":"2018"},{"key":"10.3233\/JAD-231414_ref29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0161-6420(98)93601-6","article-title":"Topography of diabetic macular edema with optical coherence tomography","volume":"105","author":"Hee","year":"1998","journal-title":"Ophthalmology"},{"key":"10.3233\/JAD-231414_ref30","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/CIA.S61790","article-title":"Age-related changes in central corneal thickness in normal eyes among the adult Lithuanian population","volume":"9","author":"Galgauskas","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-231414_ref31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archophthalmol.2008.521","article-title":"Age, stature, and education associations with ocular dimensions in an older white population","volume":"127","author":"Lee","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.3233\/JAD-231414_ref32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2009.03.006","article-title":"Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis)","volume":"148","author":"Grover","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.3233\/JAD-231414_ref33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IJG.0b013e318255bb4a","article-title":"Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography","volume":"22","author":"Alasil","year":"2013","journal-title":"J Glaucoma"},{"key":"10.3233\/JAD-231414_ref34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/aos.16612","article-title":"The Finnish current care guideline for open-angle glaucoma","volume":"102","author":"Leinonen","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.3233\/JAD-231414_ref35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000317072","article-title":"Axial length of myopia: A review of current research","volume":"225","author":"Meng","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.3233\/JAD-231414_ref36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/IJG.0b013e318193c2be","article-title":"Myopia affects retinal nerve fiber layer measurements as determined by optical coherence tomography","volume":"18","author":"Rauscher","year":"2009","journal-title":"J Glaucoma"},{"key":"10.3233\/JAD-231414_ref37","doi-asserted-by":"crossref","first-page":"100988","DOI":"10.1016\/j.eclinm.2021.100988","article-title":"High cerebrospinal amyloid-\u03b2 42 is associated with normal cognition in individuals with brain amyloidosis","volume":"38","author":"Sturchio","year":"2021","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-231414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:58:24Z","timestamp":1777370304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-231414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":37,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-231414","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}